FDA expected to issue new warning on J&J COVID jab

The US FDA is expected to issue a new warning for Johnson & Johnson’s COVID-19 vaccine, linking it to a rare autoimmune disorder, The Washington Post reported on Monday.

The United States Food and Drug Administration (FDA) is preparing to issue a new warning for Johnson & Johnson’s COVID-19 vaccine, linking it to a rare autoimmune disorder, The Washington Post reported on Monday, citing four individuals familiar with the matter. The US Centers for Disease Control and Prevention (CDC) said in a statement on Monday that about 100 preliminary reports of Guillain-Barre syndrome – a disorder in which the immune system attacks the nerves – have been detected after 12.8 million doses of J&J’s COVID-19 jab in the US. Most cases of the rare disease were reported in people aged 50 years and older, usually two weeks after receiving the vaccination.